Evidence map›Paper›PMID 36036157›Full record

ArticleInternational journal of immunopathology and pharmacology

A new indicator: The diagnostic value of CD8+T/B lymphocyte ratio in sepsis progression.

Yizhi Peng, Xiaofan Wang, Sheng Yin, Min Wang

Abstract read
In one paragraph

Article in International journal of immunopathology and pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yizhi PengDepartment of Laboratory Medicine, 70566The Second Xiangya Hospitalof Central South University, Changsha, Hunan, China.ORCID https://orcid.org/0000-0003-1709-3445
Xiaofan WangDepartment of Laboratory Medicine, 70566The Second Xiangya Hospitalof Central South University, Changsha, Hunan, China.ORCID https://orcid.org/0000-0003-4665-4600
Sheng YinDepartment of Laboratory Medicine, 70566The Second Xiangya Hospitalof Central South University, Changsha, Hunan, China.ORCID https://orcid.org/0000-0002-7253-2191
Min WangDepartment of Laboratory Medicine, 70566The Second Xiangya Hospitalof Central South University, Changsha, Hunan, China.ORCID https://orcid.org/0000-0002-3420-4031

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo reveal the value of single lymphocyte subpopulation and their ratios in the progression of sepsis.

methodsFrom January 2019 to March 2021, 39 sepsis patients, 16 septic shock patients, and 50 healthy volunteers were recruited in the Second Xiangya Hospital for this cross-sectional study. The absolute quantitation of CD4+T, CD8+T, B lymphocytes, and NK cells in peripheral blood were determined by flow cytometry. SPSS Software was used to analyze the results.

resultsOn the whole, the numbers of lymphocytes in the sepsis group and in the septic shock group were lower than that in the healthy control group. Surprisingly, the percentage of CD8+T lymphocytes in the septic shock group was slightly higher than that in the sepsis group. The percentage of B lymphocytes in the sepsis group was higher than that in the healthy control group. The AUC of CD8+T/B was 0.724, with the sensitivity and specificity being 75.00% and 71.79%, respectively.

conclusionThe immune expression pattern of patients with sepsis was not a simple decrease in the number of lymphocytes. The change in the ratios of lymphocyte subpopulation might be more meaningful along the development and progression of sepsis. The ratio of CD8+T/B could be used to diagnose the progression of sepsis and reduce the misdiagnosis rate to a certain extent.

Indexed as

SepsisShock, SepticB-LymphocytesCD8-Positive T-LymphocytesCross-Sectional StudiesHumansLymphocyte Countdiagnosislymphocyte subpopulationsepsisseptic shock

Identifiers

PMID36036157
PMCPMC9421217

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.